PS090 Association Between Gender and Mortality in Patients With Established Cardiovascular Disease
Cardiovascular disease (CVD) is a major cause of mortality worldwide. In longtime series of patients with CVD, this mortality is around 25% (14 years) and effect of gender still controversial. Some studies report that absolute incidence of CVD-related deaths is higher in women than men. However, other studies describe higher mortality rates for male gender. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: H. Ilarraza-Lomel í, M. García-Saldivia, E. Lugo-Torres, J. Rojano-Castillo, O. Sifuentes, J. Aviés-Rosales, M.-D. Rius-Suárez, M.-E. Franco-Ojeda, R. Chávez-Domínguez, J.-P. Nuñez-Urquiza Tags: Poster Abstract Source Type: research
PS091 National Registry of Cardiac Rehabilitation Programs in Mexico Ii (Renaprec Ii)
In Mexico every year, more than 100,000 deaths and a loss of USD $61 thousand of millions of dollars are associated with cardiovascular diseases (CVD). Added to this, 250,000 patients are discharged alive after a CVD hospitalization. Cardiac rehabilitation and prevention programs (CRP) are worldwide recommended for patients with CVD, however they still underused. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: H. Ilarraza-Lomeli, M. Garcia-Saldivia, J. Rojano-Castillo, S. Justiniano-Cordero, Z.-L. Aranda-Ayala, M.-D. Rius-Suarez, N. Ceron-Enriquez, L. Martinez-Ramirez, J. Lara-Vargas, A. Hernandez-Gonzalez, Mexican Society for Heart Care Working Group Tags: Poster Abstract Source Type: research
PS096 Control of Renal Parameters Essential in Improving Heart Failure Prognosis
Despite recent advances in disease management, heart failure still remains amongst the most lethal medical conditions, with 6 –12 months mortality and re-hospitalization rates of 9–15% and 30–45%, respectively. Among potential factors that contribute to this poor prognosis is the presence of comorbidities; one such major comorbidity being acute renal failure. This organ interaction, termed as the cardio-renal syndrom e (CRS), is a complex phenomenon in which malfunction of one organ consequently leads to mpairment of the other. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: L.A. Anwer, M.A. Shareef, A.S. Obad, M. Al-Harbi, F. Kavata, S.T. Al-Qallaf, B. Al Ghamdi Tags: Poster Abstract Source Type: research
PS100 Heart Failure as an Initial Manifestation of Antiphospholipid Syndrome
Primary Antiphospholipid Syndrome is characterized as an inflammatory disease; it produces recurrent arterial and venous thrombosis, recurrent fetal losses, and thrombocytopenia in association with the presence of antibodies to phospholipids in the serum. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: K.Y. Juarez, J.E. Cruz Alvarado, F.J. Leon Hernandez, M.E. Guevara Valdivia, P.I. Orosa Fernandez Tags: Poster Abstract Source Type: research
PS101 Evaluation of Patients According to Ejection Fraction Admitted for Heart Failure at the Police Hospital
Our particular population had high insidence in risk factors and coronary disease. This fact generates high incidence of heart faliure and hospitalizations with decompensated heart failure. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: S. Mettini, S.M. Pereiro Gonzalez, L. Secco, D.A. Fernandez, M.G. Masuelli, N.M. Nieves Piazza, F. Toscano, J.P. Ramos, I.L. Ramella Tags: Poster Abstract Source Type: research
PS103 Experience with Veno-Venous ECMO in Patients with Severe ARDS
Extracorporeal membrane oxygenation (ECMO) is often the last resort for serious acute respiratory distress syndrome (ARDS) when all non-invasive treatment options have failed to improve the patient ’s pulmonary condition. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: T. Strecker, J. R ösch, S. Oehrlein, M. Weyand Tags: Poster Abstract Source Type: research
PS105 Impaired Immune Phenotype of Circulating Endothelial-Derived Microparticles in None-Diabetic Patients with Chronic Heart Failure
Insulin resistance (IR) is considered a predictive biomarker in chronic heart failure (CHF). (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: A.E. Berezin, A.A. Kremzer Tags: Poster Abstract Source Type: research
PS109 Prevalence of Dilated Cardiomyopathy and Reduced Ejection Fraction in Chronic Kidney Disease
Chronic kidney disease is highly prevalent in our country and its treated usually with peritoneal dialysis and hemodialysis. It is also well-known association between chronic kidney disease and cardiovascular complications. The prevalence of congestive heart failure and Dilated cardiomyopathy is elevated in these patients and we have not enough studies on the subject for which this study was performed. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: I. Guzman Melgar, C.E. Garcia Martinez, E.F. Hernandez Paz, H. Mendizabal Tags: Poster Abstract Source Type: research
PS110 GSTM1 Null Genotype Isn ’t Associated With Increased Risk of Chronic Heart Failure Among Patients With Diabetes Mellitus
Type-2 diabetes mellitus (T2DM) is a major risk factor for coronary artery disease and ischaemic cheart failure (IHF) resulting in high morbidity and mortality. Glutathione S-transferases M1 are known for their broad range of detoxification. Approximately 50% of white population are homozygous for deletion in GSTM1. Individuals who inherit the homozygous form of the null polymorphism in these genes are less capable of detoxifying specific substrates. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: N. Jankovic, D.V. Simic, S. Radovanovic, O. Gudelj, S. Suvakov, V. Coric, T. Simic Tags: Poster Abstract Source Type: research
PS112 The Role of CT-apelin on Identifying Non-Responders to Cardiac Resynchronization Therapy
Despite cardiac resynchronization therapy (CRT), almost a third of the heart failure patients fail to develop reverse remodeling. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: B. Merkely, A. Kosztin, G. Szeplaki, A. Kovacs, G. Foldes, I. Szokodi, V.K. Nagy, V. Kutyifa, L. Geller, D. Becker, D. Aradi Tags: Poster Abstract Source Type: research
PS113 Long-Term Mortality in Patients With «Early» and «Late» Response to Cardiac Resynchronisation Therapy
Response to cardiac resynchronisation therapy (CRT) can be relatively «early» and «late» but the relationship between time of the best response and long-term mortality still remains unclear. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: V. Kuznetsov, A. Soldatova, T. Enina, D. Krinochkin Tags: Poster Abstract Source Type: research
PS116 Contemporary Management of Heart Failure With Reduced Ejection Fraction in Russia: Lessons Learned From the Russian Hospital Heart Failure Registry (RUS-HFR)
Registries remain the primary source of real-world data on hospitalized HF patients. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: E. Lyasnikova, M. Sitnikova, M. Trukshina, A. Yurchenko, E. Shlyakhto, D. Duplyakov, R. Libis Tags: Poster Abstract Source Type: research
PS118 The Impact of Coronary Vessels Stenting on the One-Year Prognosis in Patients With Chronic Coronary Artery Disease and Low Ejection Fraction
Percutaneous coronary interventions are increasingly proving their need for modern cardiology practice. However, their efficacy in coronary heart disease complicated by heart failure is controversial. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: G. Nagaeva Tags: Poster Abstract Source Type: research
PS119 The Failing Endocrine Heart: Congestive Symptomatology
Traditionally,heart failure(HF) has been considered as failure in contractile function or cardiac output. Recently, the endocrine function of the heart, with natriuretic peptides(NP) regulating intravascular volume, has been recognised,opening the possibility to consider endocrine failure as an aspect concomitant to or independent of contractile capacity.The ability to separately assess endocrine and contractile failure in clinical practice in a non-invasive fashion could improve patient care. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: A.B. Noriega Jalil, L. Camacho Reyes, M.J. Flores P érez Tags: Poster Abstract Source Type: research
PS120 Impact of Functional Mitral and Tricuspid Regurgitation on Mortality in Asian Patients With Reduced and Preserved Ejection Heart Failure
Severity of mitral regurgitation (MR) has been shown to affect mortality in patients with reduced ejection fraction (EF). However, the role of functional MR and tricuspid regurgitation (TR) in patients with preserved EF remains unclear. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: W. Ong, J. Yap, T. Shen, D. Sim, C.P. Lim, S.Y. Chia, L.L. Sim, C.K. Ching, K.K. Yeo Tags: Poster Abstract Source Type: research
